Two stories on brucellosis in Kenya by Fèvre, Eric M.
Two stories on Brucellosis in Kenya
Presented by Eric Fèvre
www.zoonotic-diseases.org
Twitter: @ZoonoticDisease
Institute for Infection and Global Health (IGH), University of Liverpool
and
International Livestock Research Institute, Nairobi
Brucellosis in Kenya - Epidemiology and 
Human Burden of a Neglected Zoonotic 
Disease
Matilda Brink and Eric Fèvre
(with the collaboration of Eric Osoro  and Stella Kiambi, ZDU)
Kenya national scale
Kenya’s District Health Information System 
(DHIS) (www.hiskenya.org)
All public hospitals and most private clinics 
Number of brucellosis diagnoses on yearly 
basis was extracted for each of the 286 
administrative districts listed in DHIS. Datasets 
were MOH 705A&B
2011 and 2012 (the only years that had a 
report rate above 70%)
286 districts was merged into 157 districts 
present at 2009 census
Cases were assumed to have been infected 
and diagnosed in their district of residence.
Denominator population: “Rural Urban 
Population by Age, Sex, and by District –
2009” from opendata.go.ke
Frequency of districts reporting Brucella in 2012
77,973 cases of human brucellosis were reported to the Kenyan Health 
Information System
75,256 of these cases came from the population >5
Majority of districts reported less than 250 cases (uneven national 
distribution)
Spatial distribution of reported brucella (2012)
Spatial scan statistic to detect spatial clustering (and its location)
Clustering analysis revealed several significant spatial clusters of cases
In the over-5 age group in 2012, the primary cluster included 26 districts in the Rift 
Valley area
Secondary clusters consisted of single districts
A – over 5s; 
B – under 5s
Annual incidence
Could not use data for prevalence – no estimate of population at risk
The annual incidence rate of brucellosis diagnosis in Kenya 2012 was 202 
per 100,000 people
Uneven:
0 - 1469 cases per 100,000 people
Incidence standardized by age structure – no significant impact
DALY for Brucella in Kenya
Based on a reported number of 77,937 
brucellosis cases in 2012
DALYs estimated for males, females and for 
the total population
Assuming an average disease duration of six 
months
Disability weight of 0.19, but no mortality
DALY for Brucella in Kenya
Total DALYs lost were 7352, or 0.190 DALYs per 1000 
people
Explored DALYs lost with under-reporting estimates
Under-reported assumed to be in the community and 
not treated
 DALYs lost DALYs per 1000 people 
Males 4862 0.253 
Females 2490 0.128 
Total 7352 0.190 
 
DALY for Brucella in Kenya
Burden of malaria 2,062,605 DALYs (9,332,421 
reported outpatient cases)
Typhoid fever 163,440 DALYs (632,129 reported 
cases)
Schistosomiasis 313 DALYs (35,420 reported cases)
 Degree of underestimation 
 0% 5% 20% 50% 75% 99% 
Number of cases 77973 81872 93568 116960 136453 155166 
Number of deaths 0 8 31 78 117 154 
DALYs lost 7352 9941 17656 33097 45930 58254 
DALYs per 1000 people 0.190 0.257 0.457 0.857 1.19 1.51 
 
DALY for sSA based on Kenya
Extrapolating Kenyan incidence data to sub-Saharan 
Africa
Disease Burden in Sub-Saharan Africa (DALYs) 
Brucellosisa (reported cases only) 140,220 
Brucellosisa (incl. 50% underestimation) 632,400 
Brucellosisa (incl. 90% underestimation) 1,114,000 
Malariab 30,900,000 
Schistosomiasisb 1,500,000 
Hook-worm diseaseb 377,000 
Hepatitis Bb 355,000 
Leishmaniasisb 328,000 
Leprosyb 25,000 
 
Summary
Brucellosis widespread in Kenya
Incidence higher than most countries reported in a recent systematic review (Dean 
2012) – but did not report much African data (which is itself a problem)
Inclusion of Brucella in the DHIS is a great start for passive surveillance
Some active surveillance is also required for such diseases that are believed to be 
severely under-ascertained and underreported (WHO, 2011)
Report rates in DHIS were 73% in 2011, 90% in 2012
Work towards a mathematical model of under-detection based on existing data and 
models (eg rabies, trypanosomiasis….)
There is an urgent need to validate the currently available tests against each 
other
Which test is most appropriate for use under Kenyan conditions
Need for guidance on false positives/false negatives and confirmatory test
Caveats
Numbers reported here regarding cases, 
incidence and DALYs must be interpreted with 
caution
Parameters for DALY calculation remain a little 
uncertain (duration, disability weight….)
We need a good spatial dataset to represent 
the DHIS in the new administrative system!
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Western Kenya – The People, Animals and their 
Zoonoses project (PAZ)
Neglected zoonoses
Under-represented in terms of knowledge, research, policy and funding
Lack of epidemiological and other data
Lack of adequate technologies and treatments
Lack of acknowledgement and attention from professional groups
Occur in marginalised communities and individuals
Zoonoses with clear link to poverty
Cysticercosis
Leptospirosis
Bovine TB
Trypanosomiasis
RVF
Q-fever
Brucellosis
Rabies
Echinococcus
Fascioliasis
Anthrax
What research is needed? - WHO
Field epidemiological studies in humans and livestock
the number of cases and number of deaths
number of new infections
age-and sex-specific disability weights for zoonoses
Estimates/models of under-reporting
Much recent progress: rabies, sleeping sickness
Case studies to gather an evidence-base
Multi-disease studies – what is the overall burden of zoonoses 
as a group on communities
Public health
Economics
Field-level diagnostics
Cost-effectiveness studies – dual medical/veterinary benefits
Pathogen and host ecology
(its not just about drugs and vaccines)
People, Animals and their Zoonoses (PAZ)
Integrated research programme that addresses this lack of data and these 
scientific aims
Aims to address both (veterinary) public health and ‘biological’ questions
Epidemiology – population scale
Framework that can be repeated elsewhere in different communities and 
ecologies
Food chain Domestic animals
Peri-
domestic
wildlife
Humans
Environment
Study site
Field site is the Western Province of 
Kenya
2000 km2 zone (500,000 cattle, 
67,000 pigs, ~1 million people)
Small-holder crop-livestock 
production system in the Lake Victoria 
Crescent (highest human and 
livestock densities in East Africa)
Intensively and comprehensively 
sampled over 2.5 years
Cluster design (random household), 
organised by sub-location units
All sublocations in the study site to be 
sampled, proportionally by cattle 
population distribution
The project is focused on…
Field site (Busia field station)
Established with Wellcome Trust 
project funding - diagnostic 
laboratory in rural western Kenya
Joint human and animal field 
teams and laboratories housed 
together
Mainly parasitology, microbiology 
and sample preparation, 
networked data entry
Recent addition of molecular and 
ELISA capability at the field lab
High-end laboratory infrastructure 
(up to BSL-3) in Nairobi
A lateral flow assay was used as primary screening test for brucellosis 
in sympatric animals and people.
- Rapid and simple
- Good performance
- Animal and human tests
- A bit expensive
2116 people in 416 homesteads
LFA :  0.71% (95% C.I. 0.38 – 1.17)
RBT : 0.06% (95% C.I. 0.0014 – 0.32)
No relationship between animal and human sero-status at the household level
We found:
893 cattle in 230 homesteads
LFA :  0.31% (95% C.I. 0.06 – 0.89)
Further surveillance based on central point sampling 
Seroprevalence based on RBT  < 0.5%
But, brucellosis apparently a common diagnosis in district and 
sub-district hospitals in study area....
So, we went to investigate.
Rose Bengal 
Brucella Agglutination Test
Lateral Flow Assay
+ve
A population of 827 
brucellosis suspects
A population of 827 
brucellosis suspects
BAT: 19.7% 
A population of 827 
brucellosis suspects
RBT: 0.6% 

5% of reactive BAT 
confirmed on LFA
So, brucellosis appears to be rare and over-diagnosed using 
current diagnostic approaches in western Kenya.
Limits use of people as ‘sentinels’ for zoonotic disease in 
animals.
.....‘one-health’
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